LRMR · Larimar Therapeutics, Inc.
$4.11
+0.06 (+1.48%)
At close · Aug 25
Going-concern doubt
— flagged Aug 4, 2026
Substantial doubt about the company's ability to continue as a going concern.
“these cash resources are not sufficient to fund the Company's planned operations for a period of at least one year from the date these unaudited condensed consolidated financial statements are issued. ... There is no assurance, however, that additional financing will be available when needed or that the Company will be able to obtain financing on terms acceptable to the Company. ... These conditions raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 4, 2026
Market Cap
$421.97M
Shares
103.88M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.